Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387543 · ClinicalTrials.gov registry record
Alpha Lipoic Acid for Burning Mouth
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 200
- Enrollment target
NCT00387543: Completed study, sponsored by Mayo Clinic.
NCT00387543 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00387543 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2000-01 |
| Est. Completion | 2007-07 |
What the finished NCT00387543 record still lists
NCT00387543 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00387543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00387543 about?
NCT00387543 is a clinical study titled "Alpha Lipoic Acid for Burning Mouth". Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.
What is the current status of trial NCT00387543?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2000-01. Estimated completion is 2007-07.
Who is sponsoring clinical trial NCT00387543?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia